U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C17H19N
Molecular Weight 237.3395
Optical Activity ( + / - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Tametraline, (+/-)-

SMILES

CN[C@@H]1CC[C@@H](C2=CC=CC=C2)C3=C1C=CC=C3

InChI

InChIKey=NVXPZMLRGBVYQV-WMLDXEAASA-N
InChI=1S/C17H19N/c1-18-17-12-11-14(13-7-3-2-4-8-13)15-9-5-6-10-16(15)17/h2-10,14,17-18H,11-12H2,1H3/t14-,17+/m0/s1

HIDE SMILES / InChI

Molecular Formula C17H19N
Molecular Weight 237.3395
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

Tametraline (also known as CP-24,441) is a norepinephrine-dopamine reuptake inhibitor that was developed as an Antidepressant agent. Information about the current use of this drug is not available.

Approval Year

PubMed

Substance Class Chemical
Record UNII
JAK4M6S8U3
Record Status Validated (UNII)
Record Version